Company

About RegSig

Portfolio-aware regulatory intelligence: normalized products mapped to scored, evidence-linked signals—so concentration, exposure, and ownership stay visible.

Company overview

RegSig is regulatory signal intelligence for teams managing real product portfolios across jurisdictions and authorities—structured signals joined to normalized product profiles executives can scan and operators can execute.

RegSig Inc. is a subsidiary of On the M.A.R.C. Holdings LLC, a Delaware company.

What we do

Built for food and nutrition supply chains and adjacent regulated operators who need governed structure—not inbox triage. Two coupled layers: a signal record (provenance, scores, horizon, actions) and portfolio assessment rows (exposure, owner, urgency, narrative).

Portfolio intake — Spreadsheet or PDF paths into validated product profiles so mapping is repeatable.
Signal intelligence — Consolidated records with origin metadata and evidence-linked detail suitable for review and audit questions.
Concentration & ownership — Leadership sees where risk piles up; operators see the rows to work with clear next steps.
Workflow fit — Outputs are oriented to triage and handoff—complementary to counsel review and existing GRC or workflow tools.

We reduce ambiguity in what changed, what it touches, and who should act—without replacing legal judgment or organizational sign-off.

Product philosophy

RegSig is an operational intelligence layer—not a generic analytics demo.

Clarity over raw volume — prioritize what matters for the portfolio you actually run.
Decision support over charts — scores and posture summarize triage; evidence supports validation.
Traceability over black boxes — mappings tie back to signal records and source context.

If it cannot be explained to a reviewer from the data model, it does not belong in the core story.

What RegSig is not

Explicit limits—for governance and procurement conversations.

Not legal advice or a substitute for counsel.
Not regulatory filing or submission automation.
Not a replacement for your organization’s own review and sign-off.
Not a passive document repository unrelated to signals and portfolio assessment.

Organization

RegSig operates as a portfolio company of On the M.A.R.C. Holdings.

Leadership & team

Glenn Ballard

Bio

Glenn Ballard is a seasoned executive, business owner, and high-impact leader with over 30 years of experience driving growth. With a career defined by strategic precision and a relentless pursuit of excellence, Glenn has established himself as a force within the food and healthcare industries - two of the most complex and essential sectors in the global economy. Before transitioning into business ownership, Glenn spent more than two and a half decades navigating the intricacies of the corporate environment. Holding a series of sales and marketing leadership positions, his tenure in the corporate sector was marked by an uncanny ability to identify emerging market trends and translate them into actionable, revenue-generating strategies and execution. Today, Glenn serves as a business owner in the healthcare consumable space. Under his stewardship, his current ventures have scaled rapidly, now accounting for millions of dollars in revenue. Glenn's approach is rooted in the belief that business is about more than just financial metrics - it is about creating sustainable systems where innovation can thrive by creatively answering customer needs.

LinkedIn profile

Preetam "PK" Dandapani

Bio

Preetam has 15+ years of corporate finance and capital markets experience in the energy sector. Mr. Dandapani was the CFO of Evolution Midstream where he played a key role directing the company's strategy and was responsible for $150+ million of capital investments. Prior to Evolution, Mr. Dandapani led corporate development at DCP Midstream and was an investment banker in the Global Energy group at Credit Suisse.

LinkedIn profile

Elizabeth J. Johnson

Bio

Elizabeth J. Johnson, PhD, FASN, FACN, FICS, is a nutritional biochemist and faculty member at the Friedman School of Nutrition Science & Policy at Tufts University. With over 35 years of expertise, Dr. Johnson specializes in nutrition and healthy aging, specifically exploring how nutrients and bioactives impact health across the lifespan. As a strategic consultant for the global food and supplement industries, she leverages emerging technologies to enhance product efficacy and innovation. A recognized scientific leader, Dr. Johnson provides expert guidance on nutrition policy and regulatory substantiation, ensuring that health, nutrient content, and structure/function claims meet rigorous FDA standards.

LinkedIn profile

Aaditya Khemuka

Bio

Aaditya is an experienced investment banker with over 20 years of experience in investment banking and consulting. As a healthcare startup founder, he co-founded a digital health venture backed by Eureka Forbes. He brings deep access across the healthcare ecosystem, including pharmaceuticals, medical devices, and care delivery. He has lived and worked in New York, Paris, London, and Mumbai.

LinkedIn profile

Michael F. Marcotte

Bio

Michael Frederick Marcotte is a visionary aviator, rocket engineer, technology leader, cybersecurity pioneer, quantum physicist, and international security advisor. His life has bridged air, earth, and code — from launching satellites to shaping global cybersecurity, from quantum research to humanitarian service. He served as President of Hughes and Global Chief Information Officer at EchoStar/DISH Network, and has held senior leadership roles in over seven global corporations. A co-founder of the United States National Cybersecurity Center (NCC) and founder of its National Rapid Response Center, Michael has devoted his career to the protection of people, systems, and truth.

LinkedIn profile

Chet Rao

Bio

Chet has 20+ years experience in consumer products and healthcare. He has experience at Fortune 200 companies and large healthcare institutions. Dr. Rao has demonstrated track record in strategic transactions, both buy and sell-side, for deal values ranging from $5–$500 MM. Dr. Rao is a seasoned executive with a proven track record in general management, innovation, and M&A.

LinkedIn profile

Praneet Sah

Bio

Praneet works at Rosten Capital, where he oversees Opportunity Fund 1, a real estate-focused fund targeting high-potential opportunities in India. An entrepreneur at heart, he brings a diverse skill set spanning deal making, software, and finance — allowing him to evaluate investments through both a technical and financial lens. With experience building and scaling ventures from the ground up, Praneet combines hands-on operational knowledge with strategic thinking to identify and execute on compelling opportunities. Praneet has BS in Computer Science from UC Irvine and a Series 65 license.

LinkedIn profile

Governance & access

Trajectory-aware signals stay tied to evidence and portfolio impact—built for operator review, not opaque alerts.

Start with individual usage-based access when you are ready. Enterprise teams use institutional onboarding with fit and governance review.

Individual usage-based access Request institutional access

Human-in-the-loop review stays in operator workflows.
Recommendations remain evidence-linked and auditable.
Portfolio mapping is role-aware with explicit ownership.